|Day Low/High||1.76 / 1.85|
|52 Wk Low/High||2.31 / 23.50|
We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.
We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.
We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
We booked some profits in Huntington Bancshares and SLM this week and cut our rating on SLM from One to Two.
Holding an above-average cash position after peeling profits off the table into the most recent rally.
We again have an above-average cash position after peeling profits off the table into the most recent rally.
We booked some profits in Synovus Financial and used part of the proceeds to buy more Yamana Gold.
We sold the rest of our Datalink holdings and will use the proceeds to add a name to our portfolio.
We used this week's declines to add to our position in Jive Software and Sonus Networks.
We used this week's declines to add to our positions in Teligent, Builders FirstSource and Sonus Networks.
We used this week's declines to add to our positions in Teligent and Sonus Networks.
The investigation found that the company did not realize any financial loss from the questioned dealings of its former CEO and former chairman.